Form 4: UnitedHealth Group Director Paul R. Garcia Acquires Additional Shares Through Dividend Equivalents

Paul R. Garcia, a Director at UnitedHealth Group Inc. (UNH), has acquired 11 shares of common stock through dividend equivalents on vested deferred stock units.

Summary

• Paul R. Garcia, a Director of UnitedHealth Group Inc. (UNH), acquired 11 shares of common stock on June 24, 2025.
• The acquisition was made at a price of $0 per share, representing dividend equivalents paid on vested deferred stock units.
• These dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
• Following this transaction, Mr. Garcia's beneficial ownership includes 2,481 shares held directly, 2,146 shares held indirectly by a Revocable Trust, 45 shares held indirectly by Trust 2, and 55 shares held indirectly by Trust 3.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as a director is increasing their stake in the company, albeit through dividend equivalents rather than a direct purchase. This indicates continued alignment of interests.

Positives

• The acquisition of 11 shares through dividend equivalents indicates a continued accumulation of equity by a director, aligning their interests with shareholders.
• The shares are immediately vested, providing the director with immediate beneficial ownership.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide broader industry context or trends, but rather reflects a director's personal equity holdings in the healthcare sector's largest company, UnitedHealth Group.

Related Party Transactions

• The transaction involves a director of UnitedHealth Group acquiring shares from the company, which is a common form of related party transaction in the context of executive compensation and equity plans.

Stakeholder Impact

• Shareholders: The transaction shows a director's continued equity interest, which can be viewed positively as it aligns management's interests with shareholder value.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Recommendation

Keywords

UnitedHealth Group, UNH, Paul R. Garcia, SEC Form 4, Insider Transaction, Director Stock Acquisition, Dividend Equivalents, Deferred Stock Units, Beneficial Ownership